| Dr Kristyn Warken Payne, MD | |
|
9303 Pinecroft Dr, Suite 150, The Woodlands, TX 77380-3180 | |
| (281) 363-5050 | |
| (281) 363-5020 |
| Full Name | Dr Kristyn Warken Payne |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 22 Years |
| Location | 9303 Pinecroft Dr, The Woodlands, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1780628644 | NPI | - | NPPES |
| 7941899 | Other | AETNA | |
| P00455498 | Other | RAILROAD MEDICARE | |
| 8J5522 | Other | TX | BLUE CROSS BLUE SHIELD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | M2443 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Michael Sonabend Md Pa | 6901045665 | 20 |
News Archive
GlaxoSmithKline and XenoPort, Inc. announced today that GSK1838262/XP13512 (gabapentin enacarbil) did not demonstrate a statistically significant improvement compared to placebo as a prophylactic treatment for migraine headaches. This phase 2b dose-ranging study evaluated the efficacy, safety and tolerability of GSK1838262 in adults diagnosed with migraine headache (with or without aura) according to the International Headache Society criteria.
Researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute report a discovery that helps scientists understand why some tumors lack immune cell infiltration and are therefore unresponsive to newer PD-1 targeted therapies.
Time is of the essence when getting people stricken with acute ischemic strokes to treatment. And the use of stent retrievers — devices that remove the blood clot like pulling a cork out of a wine bottle — has proven to be a breakthrough for removing the life-threatening blockage of blood flow to the brain.
Emerging Healthcare Solutions, Inc. announced today that it has received the honor of admission to the President's Club of the National Black Chamber of Commerce www.nationalbcc.org. Membership in the exclusive President's Club is an honor that establishes nationwide recognition of Emerging Healthcare Solutions in the healthcare industry and helps engineer policies and initiatives that benefit minority business development in healthcare.
› Verified 3 days ago
| Entity Name | The Woodlands Dermatology Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619919958 PECOS PAC ID: 0042202947 Enrollment ID: O20040331001445 |
News Archive
GlaxoSmithKline and XenoPort, Inc. announced today that GSK1838262/XP13512 (gabapentin enacarbil) did not demonstrate a statistically significant improvement compared to placebo as a prophylactic treatment for migraine headaches. This phase 2b dose-ranging study evaluated the efficacy, safety and tolerability of GSK1838262 in adults diagnosed with migraine headache (with or without aura) according to the International Headache Society criteria.
Researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute report a discovery that helps scientists understand why some tumors lack immune cell infiltration and are therefore unresponsive to newer PD-1 targeted therapies.
Time is of the essence when getting people stricken with acute ischemic strokes to treatment. And the use of stent retrievers — devices that remove the blood clot like pulling a cork out of a wine bottle — has proven to be a breakthrough for removing the life-threatening blockage of blood flow to the brain.
Emerging Healthcare Solutions, Inc. announced today that it has received the honor of admission to the President's Club of the National Black Chamber of Commerce www.nationalbcc.org. Membership in the exclusive President's Club is an honor that establishes nationwide recognition of Emerging Healthcare Solutions in the healthcare industry and helps engineer policies and initiatives that benefit minority business development in healthcare.
› Verified 3 days ago
| Entity Name | Michael Sonabend Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952642738 PECOS PAC ID: 6901045665 Enrollment ID: O20130611000075 |
News Archive
GlaxoSmithKline and XenoPort, Inc. announced today that GSK1838262/XP13512 (gabapentin enacarbil) did not demonstrate a statistically significant improvement compared to placebo as a prophylactic treatment for migraine headaches. This phase 2b dose-ranging study evaluated the efficacy, safety and tolerability of GSK1838262 in adults diagnosed with migraine headache (with or without aura) according to the International Headache Society criteria.
Researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute report a discovery that helps scientists understand why some tumors lack immune cell infiltration and are therefore unresponsive to newer PD-1 targeted therapies.
Time is of the essence when getting people stricken with acute ischemic strokes to treatment. And the use of stent retrievers — devices that remove the blood clot like pulling a cork out of a wine bottle — has proven to be a breakthrough for removing the life-threatening blockage of blood flow to the brain.
Emerging Healthcare Solutions, Inc. announced today that it has received the honor of admission to the President's Club of the National Black Chamber of Commerce www.nationalbcc.org. Membership in the exclusive President's Club is an honor that establishes nationwide recognition of Emerging Healthcare Solutions in the healthcare industry and helps engineer policies and initiatives that benefit minority business development in healthcare.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kristyn Warken Payne, MD 9303 Pinecroft Dr, Suite 150, The Woodlands, TX 77380-3180 Ph: (281) 363-5050 | Dr Kristyn Warken Payne, MD 9303 Pinecroft Dr, Suite 150, The Woodlands, TX 77380-3180 Ph: (281) 363-5050 |
News Archive
GlaxoSmithKline and XenoPort, Inc. announced today that GSK1838262/XP13512 (gabapentin enacarbil) did not demonstrate a statistically significant improvement compared to placebo as a prophylactic treatment for migraine headaches. This phase 2b dose-ranging study evaluated the efficacy, safety and tolerability of GSK1838262 in adults diagnosed with migraine headache (with or without aura) according to the International Headache Society criteria.
Researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute report a discovery that helps scientists understand why some tumors lack immune cell infiltration and are therefore unresponsive to newer PD-1 targeted therapies.
Time is of the essence when getting people stricken with acute ischemic strokes to treatment. And the use of stent retrievers — devices that remove the blood clot like pulling a cork out of a wine bottle — has proven to be a breakthrough for removing the life-threatening blockage of blood flow to the brain.
Emerging Healthcare Solutions, Inc. announced today that it has received the honor of admission to the President's Club of the National Black Chamber of Commerce www.nationalbcc.org. Membership in the exclusive President's Club is an honor that establishes nationwide recognition of Emerging Healthcare Solutions in the healthcare industry and helps engineer policies and initiatives that benefit minority business development in healthcare.
› Verified 3 days ago
Dr. Andrew Decrescenzo, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9303 Pinecroft Dr Ste 310, The Woodlands, TX 77380 Phone: 281-363-5050 Fax: 281-363-5020 | |
Amy C Bumgardner, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9303 Pinecroft Dr, Suite 150, The Woodlands, TX 77380 Phone: 281-363-5050 | |
Stephen B Tucker, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 1055 Evergreen Cir, The Woodlands, TX 77380 Phone: 281-367-9110 Fax: 832-813-0344 | |
Dr. Brent Andrew Shook, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8850 Six Pines Drive, Suite 290, The Woodlands, TX 77380 Phone: 281-364-8844 Fax: 281-364-8833 | |
Dr. Haneol Sam Jeong, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9303 Pinecraft Drive, Suite 150, The Woodlands, TX 77380 Phone: 281-363-5050 Fax: 281-363-5020 | |
Dr. Nhan Minh Nguyen, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 17183 I 45 Suite 510, The Woodlands, TX 77385 Phone: 713-791-9966 | |
Mandy Sue Harting, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 9303 Pinecroft Dr, Suite 150, The Woodlands, TX 77380 Phone: 281-363-5050 Fax: 281-296-2072 |